Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting.

Am J Hum Genet 2019 09 15;105(3):526-533. Epub 2019 Aug 15.

Department of Medicine (Medical Genetics), University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address:

As clinical testing for Mendelian causes of colorectal cancer (CRC) is largely driven by recognition of family history and early age of onset, the rates of such findings among individuals with prevalent CRC not recognized to have these features is largely unknown. We evaluated actionable genomic findings in community-based participants ascertained by three phenotypes: (1) CRC, (2) one or more adenomatous colon polyps, and (3) control participants over age 59 years without CRC or colon polyps. These participants underwent sequencing for a panel of genes that included colorectal cancer/polyp (CRC/P)-associated and actionable incidental findings genes. Those with CRC had a 3.8% rate of positive results (pathogenic or likely pathogenic) for a CRC-associated gene variant, despite generally being older at CRC onset (mean 72 years). Those ascertained for polyps had a 0.8% positive rate and those with no CRC/P had a positive rate of 0.2%. Though incidental finding rates unrelated to colon cancer were similar for all groups, our positive rate for cardiovascular findings exceeds disease prevalence, suggesting that variant interpretation challenges or low penetrance in these genes. The rate of HFE c.845G>A (p.Cys282Tyr) homozygotes in the CRC group reinforces a previously reported, but relatively unexplored, association between hemochromatosis and CRC. These results in a general clinical population suggest that current testing strategies could be improved in order to better detect Mendelian CRC-associated conditions. These data also underscore the need for additional functional and familial evidence to clarify the pathogenicity and penetrance of variants deemed pathogenic or likely pathogenic, particularly among the actionable genes associated with cardiovascular disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2019.07.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731361PMC
September 2019
3 Reads
10.931 Impact Factor

Publication Analysis

Top Keywords

positive rate
12
colon polyps
8
pathogenic pathogenic
8
colorectal cancer
8
findings individuals
8
crc
8
findings
5
rate
5
despite generally
4
generally older
4
pathogenic crc-associated
4
crc-associated gene
4
gene variant
4
crc-associated conditions
4
variant despite
4
years ascertained
4
08% positive
4
detect mendelian
4
rate crc/p
4
crc/p positive
4

Similar Publications